Latest Modus Therapeutics News & Updates

See the latest news and media coverage for Modus. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Modus Therapeutics (Modus)

Biotechnology company developing treatments for severe medical conditions

modustx.com
Headquarters
Stockholm, Sweden
Founded year
2011
Company type
Public company
Number of employees
5–10
Industry
Biotechnology & Medical Research

Last updated

Latest news about Modus Therapeutics (Modus)

In short: Modus raised SEK 7.6 million through a share issuance while advancing Phase IIa clinical trials for chronic kidney disease-related anemia.

Company announcements

Modus

Modus Therapeutics publishes interim report for Q1 2026

The report highlights disciplined execution and progress in the Phase IIa study for sevuparin, with proof-of-concept readout expected by end of 2026.

Unlock all announcements with a

Media coverage

Dagens industri

The research company makes a new issue

The research company Modus Therapeutics has decided on a targeted new issue of 20 million shares, which will bring the company 7.6 million kronor before deductions...

Investing.com

Modus Therapeutics Holding AB (MODTX)

На сегодняшний день рыночная капитализация Modus Therapeutics Holding AB составляет 45,00 млн. Какова прибыль на акцию Modus Therapeutics Holding AB (за последние 12 ...

Unlock all articles with a

Never miss news about Modus

Track Modus and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Modus competitors & trending companies

Browse news for competitors to Modus and other trending companies.